Aarti Industries Limited

NSE AARTIIND.NS

Aarti Industries Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.61

Aarti Industries Limited Debt to Equity Ratio is 0.61 for the year ending March 31, 2024, a 3.73% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Aarti Industries Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.59, a 34.42% change year over year.
  • Aarti Industries Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.44, a -46.20% change year over year.
  • Aarti Industries Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.82, a 14.84% change year over year.
  • Aarti Industries Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.71, a -22.05% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NSE: AARTIIND.NS

Aarti Industries Limited

CEO Mr. Suyog Kalyanji Kotecha
IPO Date July 1, 2002
Location India
Headquarters 71, Udyog Kshetra
Employees 6,100
Sector Health Care
Industries
Description

Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. It offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in the manufacture of intermediates with applications in agrochemicals, pharmaceuticals, polymer additives, fuel additives, FMCG, dyes, pigments, paints, printing inks, rubber chemicals, resins, and other speciality chemical applications. The company also provides active pharmaceutical ingredients, which have applications in anti-hypertensive, anti asthamatic, anti-cancer, anti thalassaemic, analgesic, ophthalmologic, and calcimimetics; central nervous system agents; and skin care and decongestant products. In addition, it offers intermediates; and xanthine derivatives, such as caffeine anhydrous, theophylline, aminophylline, acephylline piperazine, choline theophylline, doxofylline, DMAU, and theobromine derivatives, as well as contract manufacturing and research services. The company also exports its products to approximately 60 countries in North America, Europe, China, Japan, and internationally. Aarti Industries Limited was incorporated in 1984 and is headquartered in Mumbai, India.

Similar companies

DEEPAKNTR.NS

Deepak Nitrite Limited

USD 27.05

0.71%

PIIND.NS

PI Industries Limited

USD 40.01

2.00%

ATUL.NS

Atul Ltd

USD 77.84

2.00%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 41.96

0.53%

VINATIORGA.NS

Vinati Organics Limited

USD 18.82

-1.09%

StockViz Staff

January 15, 2025

Any question? Send us an email